Browse the corpus

REFERENCES Baley JE, Meyers C, Kliegman RM, et al, "Pharmacokinetics, Outcome of Treatment, and Toxic Effects of Amphotericin B and 5-Fluorocytosine in Neonates," J Pediatr , 1990, 116(5):791-7. [PubMed 2329429 ] Benson JM and Nahata MC, "Pharmacokinetics of Amphotericin B in Children," Antimicrob Agents Chemother , 1989, 33(11):1989-93. [PubMed 2610508 ] Branch RA, "Prevention of Amphotericin B-Induced Renal Impairment. A Review on the Use of Sodium Supplementation," Arch Intern Med , 1988, 148(11):2389-94. [PubMed 3056312 ] Centers for Disease Control and Prevention (CDC), "Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children," MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] Centers for Disease Control and Prevention, "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations From CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America," MMWR Recomm Rep , 2009a, 58(RR-4):1-216. Available at file://www.aidsinfo.nih.gov/contentfiles/adult_oi.pdf Chapman SW, Dismukes WE, Proia LA, et al, "Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2008, 46(12):1801-12. [PubMed 18462107 ] Chiou CC, Wong TT, Lin HH, et al, "Fungal Infection of Ventriculoperitoneal Shunts in Children," Clin Infect Dis , 1994, 19(6):1049-53. [PubMed 7888533 ] Eriksson U, Seifert B, and Schaffner A, "Comparison of Effects of Amphotericin B Deoxycholate Infused Over 4 or 24 Hours: Randomised Controlled Trial," BMJ , 2001, 322(7286):579-82. [PubMed 11238151 ] Fisher JF, Sobel JD, Kauffman CA, et al, "Candida Urinary Tract Infections-Treatment," Clin Infect Dis , 2011, 52(Suppl 6):S457-66. [PubMed 21498839 ] Galgiani JN, Ampel NM, Blair JE, et al, "Coccidioidomycosis," Clin Infect Dis , 2005, 41(9):1217-23. [PubMed 16206093 ] Gubbins PO, McConnell SA, and Penzak SR, "Current Management of Funguria," Am J Health Syst Pharm , 1999, 56(19):1929-35. [PubMed 10554910 ] Harbarth S, Pestotnik SL, Lloyd JF, et al, "The Epidemiology of Nephrotoxicity Associated With Conventional Amphotericin B Therapy," Am J Med , 2001, 111(7):528-34. [PubMed 11705428 ]

Gubbins PO, McConnell SA, and Penzak SR, "Current Management of Funguria," Am J Health Syst Pharm , 1999, 56(19):1929-35. [PubMed 10554910 ] Harbarth S, Pestotnik SL, Lloyd JF, et al, "The Epidemiology of Nephrotoxicity Associated With Conventional Amphotericin B Therapy," Am J Med , 2001, 111(7):528-34. [PubMed 11705428 ] Imhof A, Walter RB, and Schaffner A, "Continuous Infusion of Escalated Doses of Amphotericin B Deoxycholate: An Open-Label Observational Study," Clin Infect Dis , 2003, 36(8):943-51. [PubMed 12684904 ] Jeffery GM, Beard ME, Ikram RB, et al, "Intranasal Amphotericin B Reduces the Frequency of Invasive Aspergillosis in Neutropenic Patients," Am J Med , 1991, 90(6):685-92. [PubMed 2042684 ] King CT, Rogers PD, Cleary JD, et al, "Antifungal Therapy During Pregnancy," Clin Infect Dis , 1998, 27(5):1151-60. [PubMed 9827262 ] Kintzel PE and Smith GH, "Practical Guidelines for Preparing and Administering Amphotericin B," Am J Hosp Pharm , 1992, 49(5):1156-64. [PubMed 1595747 ] Klaus JR, Knodel LC, and Kavanagh RE, "Administration Guidelines for Parenteral Drug Therapy. Part I: Pediatric Patients," J Pharm Technol , 1989, 5(3):101-28. [PubMed 10318297 ] Koren G, Lau A, Klein J, et al, "Pharmacokinetics and Adverse Effects of Amphotericin B in Infants and Children," J Pediatr , 1988, 113(3):559-63. [PubMed 3411404 ] Ku JH, Kim ME, Jeon YS, et al, "Urinary Ascites and Anuria Caused by Bilateral Fungal Balls in a Premature Infant," Arch Dis Child Fetal Neonatal Ed , 2004, 89(1):F92-3. [PubMed 14711869 ] Mactal-Haaf C, Hoffman M, and Kuchta A, "Use of Anti-infective Agents During Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics," J Hum Lact , 2001, 17(2):160-6. [PubMed 11847833 ] Manley HJ, Grabe DW, Norcross M, et al, "Stability of Amphotericin B-Lipid Complex (Abelcet) in Peritoneal Dialysis Solutions," Perit Dial Int , 2000, 20(1):87-90. [PubMed 10716591 ] Martinez-Pajares JD, Martinez-Ferriz MC, Moreno-Perez D, et al, "Management of Obstructive Renal Failure Caused by Bilateral Renal Aspergilloma in an Immunocompetent Newborn," J Med Microbiol , 2010, 59(Pt 3):367-9. [PubMed 19910484 ] Murphy K, Bradley J, and James HE, "The Treatment of Candida albicans Shunt Infections," Childs Nerv Syst , 2000, 16(1):4-7. [PubMed 10672422 ]

Martinez-Pajares JD, Martinez-Ferriz MC, Moreno-Perez D, et al, "Management of Obstructive Renal Failure Caused by Bilateral Renal Aspergilloma in an Immunocompetent Newborn," J Med Microbiol , 2010, 59(Pt 3):367-9. [PubMed 19910484 ] Murphy K, Bradley J, and James HE, "The Treatment of Candida albicans Shunt Infections," Childs Nerv Syst , 2000, 16(1):4-7. [PubMed 10672422 ] Pappas PG, Kauffman CA, Andes D, et al, "Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2009, 48(5):503-35. [PubMed 19191635 ] Pappas PG, Chetchotisakd P, Larsen RA, et al, "A Phase II Randomized Trial of Amphotericin B Alone or Combined With Fluconazole in the Treatment of HIV-Associated Cryptococcal Meningitis," Clin Infect Dis , 2009, 48(12):1775-83. [PubMed 19441980 ] Peleg AY and Woods ML, "Continuous and 4 h Infusion of Amphotericin B: A Comparative Study Involving High-Risk Haematology Patients," J Antimicrob Chemother , 2004, 54(4):803-8. [PubMed 15308606 ] Perfect JR, Dismukes WE, Dromer F, et al, "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2010, 50(3):291-322. [PubMed 20047480 ] Raaijmakers R, Schröder C, Monnens L, et al, "Fungal Peritonitis in Children on Peritoneal Dialysis," Pediatr Nephrol , 2007, 22(2):288-93. [PubMed 17111161 ] Red Book: 2012 Report of the Committee on Infectious Diseases , "Antibacterial Drugs Dosage Tables," 29th ed, Pickering LK, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2012. Available at file://aapredbook.aappublications.org/cgi/content/full Turcu R, Patterson MJ, and Omar S, "Influence of Sodium Intake on Amphotericin B-Induced Nephrotoxicity Among Extremely Premature Infants," Pediatr Nephrol , 2009, 24(3):497-505. [PubMed 19082636 ] Warady BA, Schaefer F, Holloway M, et al, "Consensus Guidelines for the Treatment of Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis," Perit Dial Int , 2000, 20(6):610-24. [PubMed 11216549 ] Wheat LJ, Freifeld AG, Kleiman MB, et al, "Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(7):807-25. [PubMed 17806045 ] Topic 12647 Version 34.0

Warady BA, Schaefer F, Holloway M, et al, "Consensus Guidelines for the Treatment of Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis," Perit Dial Int , 2000, 20(6):610-24. [PubMed 11216549 ] Wheat LJ, Freifeld AG, Kleiman MB, et al, "Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(7):807-25. [PubMed 17806045 ] Topic 12647 Version 34.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0503-200.131.240.2-6FA69E1D15-S244013.14]